text: OBJECTIVES: The aim of the current study was to assess the activity of << rolipram >>, a nonsubtype-selective [[ PDE4 ]] inhibitor, in several animal models predictive of antipsychotic-like efficacy and side-effect liability and to use PDE4B wild-type and knockout mice to begin to understand the subtypes involved in the activity of rolipram.